⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7070954 | 0.98 | — | — | |
| SCHEMBL11493724 | 0.78 | — | — | |
| SCHEMBL626433 | 0.78 | — | — | |
| SCHEMBL30172905 | 0.73 | CA12 (0.46) | — | |
| SCHEMBL698657 | 0.64 | KDM4E (0.52) | — | |
| SCHEMBL243344 | 0.60 | — | — | |
| Hydrazine SCHEMBL23496608 | 0.60 | KDM4E (0.48) | — | |
| Dipicolinic Acid SCHEMBL34595 | 0.60 | KDM4E (1.00) | — | |
| Dipicolinic Acid SCHEMBL720696 | 0.60 | KDM4E (1.00) | — | |
| SCHEMBL162060 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 472 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4646271-A1 | SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES | Mirati Therapeutics, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| CN-110167944-B | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-08-23 | — | — | CN | claimed |
| WO-2024148150-A1 | SUBSTITUTED SPIROCYCLIC-PYRROLOQUINAZOLINONES AND SPIROCYCLIC-PIPERIDINOQUINAZOLINONES | Mirati Therapeutics, Inc. (US) | 2024-07-11 | — | — | WO | claimed |
| EP-3551632-B1 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | UNION THERAPEUTICS AS (DK) | 2024-06-12 | — | — | EP | claimed |
| EP-3674052-B1 | METHOD FOR PRODUCING METAL-POLYMER RESIN CONJUGATE | PLASTAL CO LTD (KR) | 2022-06-08 | — | — | EP | claimed |
| US-11235498-B2 | Manufacturing method of metal-polymer resin bonded component | PLASTAL CO., LTD. (KR) | 2022-02-01 | — | — | US | claimed |
| CN-109421207-B | Method for manufacturing metal-polymer resin bonded member | 塑料金属有限公司 | 2021-01-22 | — | — | CN | claimed |
| EP-3674052-A1 | METHOD FOR PRODUCING METAL-POLYMER RESIN CONJUGATE | Plastal Co., Ltd. (KR) | 2020-07-01 | — | — | EP | claimed |
| US-20200171722-A1 | MANUFACTURING METHOD OF METAL-POLYMER RESIN BONDED COMPONENT | PLASTAL CO., LTD. (KR) | 2020-06-04 | — | — | US | claimed |
| CN-109925545-A | A kind of injection device and preparation method thereof in autoblood purification injection | 北京华悦恒生健康管理有限公司 | 2019-06-25 | — | — | CN | claimed |
| US-5652219-A | Hemoregulatory peptides | SMITHKLINE BEECHAM CORPORATION (US) | 1997-07-29 | — | — | US | claimed |
| EP-0701446-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-04-23 | — | — | EP | claimed |
| EP-0621788-A4 | HEMOREGULATORY PEPTIDES. | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-03-05 | — | — | EP | claimed |
| EP-0725651-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-08-14 | — | — | EP | claimed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | claimed |
| WO-1995011693-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1995-05-04 | — | — | WO | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0621788-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-11-02 | — | — | EP | claimed |
| WO-1993013789-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1993-07-22 | — | — | WO | claimed |